Paul Korda . com - The Web Home of Paul Korda, singer, musician & song-writer.

International Entertainment News

Monday, November 07, 2011

"Tomorrow's Health" TV Series Showing the Life Science Industry's Quest to Save and Improve Lives, to Air on Select NBC Stations

"Tomorrow's Health" TV Series Showing the Life Science Industry's Quest to Save and Improve Lives, to Air on Select NBC Stations

SAN DIEGO, Nov. 7, 2011 /PRNewswire/ -- BIOCOM, the trade group representing Southern California's life science industry, and award-winning Phase 3 Digital have partnered to tell the biotechnology story from discovery through development. Consumers across the U.S. will soon get a glimpse into the exciting and innovative world of medical discovery that brings life-saving therapies, medical devices and diagnostics to patients around the globe. "Tomorrow's Health," a new television series created in partnership with the life sciences industry, explores some of the most exciting and promising new treatments under development.

"Tomorrow's Health" introduces viewers to patients, their doctors, and their struggle to achieve healthier lives. The program reveals the surprising truth about the challenges and obstacles biomedical researchers face in the development of cures and bringing new medicines, medical devices and diagnostics to market.

Created and produced by Phase 3 Digital, in partnership with BIOCOM, "Tomorrow's Health" will run on select NBC stations and other major network and cable channels in top media markets around the U.S. The program will feature a website and social media portals, where consumers can view episodes on demand and gain more information on companies and the featured experts.

For more information on how to be considered as a featured company, sponsorship opportunities, or other information contact Ed Personius at Phase 3 Digital, at (714) 748-0600.

SOURCE BIOCOM

BIOCOM

CONTACT: Terri Somers of BIOCOM, +1-858-455-0300, x 110, tsomers@biocom.org

Web Site: http://www.biocom.org


-------
Profile: intent

0 Comments:

Post a Comment

<< Home